Advertisement

Ads Placeholder
Loading...

Kadimastem Ltd

KMSTFPNK
Healthcare
Biotechnology
$3.21
$-0.10(-3.02%)
U.S. Market opens in 26h 3m

Kadimastem Ltd (KMSTF) Stock Overview

Explore Kadimastem Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.5M
P/E Ratio-0.81
EPS (TTM)$-6.35
ROE0.45%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$3.83
1 Year Target$2.01

KMSTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kadimastem Ltd (KMSTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $2.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.81 and a market capitalization of 9.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
18.45%
5-Day Change
8.08%
1-Month Change
1.90%
3-Month Change
-55.23%
6-Month Change
-55.23%
Year-to-Date (YTD) Change
-64.61%
1-Year Change
-64.61%
3-Year Change
-65.15%
5-Year Change
-63.02%
All-Time (Max) Change
-63.02%

Contact Information

972 73 797 1600
Pinchas Sapir 7, Ness Ziona, NaN, 74140

Company Facts

110 Employees
IPO DateFeb 1, 2021
CountryIL

Frequently Asked Questions